CymaBay
CymaBay is a biopharmaceutical company that focuses on developing therapies for liver and chronic diseases.
Business Model:
Revenue: $19.2M
Employees: 51-200
Industries / Tags:
Detailed CymaBay Information
Geographic Data
Address: 7575 Gateway Boulevard
City: Newark
State: CA
Zip: 94560
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$75M
Raised Total:$146M
Social
Metrics
9,496,388Website Global Rank
147Website Monthly Traffic
Twitter Followers
Description
CymaBay is a biopharmaceutical company that focuses on developing therapies for liver and chronic diseases.
Contact Phone:
+15102938800
Contact Email:
CymaBay went public on 7/18/2014 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/18/2014
Ticker Symbol:
CBAY
Amount Raised:
$22M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
